An integrated approach that includes a central role for pathology laboratories is necessary
Mass casualty events (MCEs) are defined as events or other circumstances “where the normal major incident response of one or several health organisations must be augmented by extraordinary measures to maintain an efficient, suitable and sustainable response”.1 Haemorrhage is a leading cause of mortality in MCEs, accounting for almost 50% of deaths in the first 24 hours,2,3 and transfusion emergency preparedness is increasingly recognised as a critical element of an integrated approach to MCEs,4 with timely availability and appropriate delivery of blood components being an essential part of management.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Ryan J, Doll D. Mass casualties and triage. In: Velmahos GC, Degiannis E, Doll D editors. Penetrating trauma. Berlin, Heidelberg: Springer, 2012: 151–159.
- 2. Glasgow S, Davenport R, Perkins Z, et al. A comprehensive review of blood product use in civilian mass casualty events. J Trauma Acute Care Surg 2013; 75: 468–474.
- 3. Holcomb JB, Jenkins D, Rhee P, Johannigman J. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007; 62: 307–310.
- 4. Doughty H, Rackham R. Transfusion emergency preparedness for mass casualty events. ISBT Sci Ser 2018; 14: 77–83.
- 5. Victorian Department of Health and Human Services. Code Brown planning – guidance note for health services and facilities, February 2017. Melbourne: State Government of Victoria, 2017. https://www2.health.vic.gov.au/about/publications/policiesandguidelines/code-brown-planning-guidance-note-for-health-services-and-facilities (viewed Dec 2019).
- 6. Mckeown D, Chowdhury F, Regan F. London 2017: a year to remember for all the wrong reasons! Vox Sang 2018; 113 (Suppl 1): 22.
- 7. Bala M, Kaufman T, Keidar A, et al. Defining the need for blood and blood products transfusion following suicide bombing attacks on a civilian population: a level I single‐centre experience. Injury 2014; 45: 50–55.
- 8. Noël S, Francois A, Le Failler F, et al. Lessons learned from Paris and Nice. ISBT Sci Ser 2018; 13: 35–46.
No relevant disclosures.